486 related articles for article (PubMed ID: 9124211)
21. Residual normal, highly proliferative progenitors can be isolated from the CD34+/33- fraction of AML with a more differentiated phenotype (CD33+).
Raymakers R; Wittebol S; Pennings A; Linders E; Poddighe P; De Witte T
Leukemia; 1995 Mar; 9(3):450-7. PubMed ID: 7533867
[TBL] [Abstract][Full Text] [Related]
22. Acute myeloid leukaemia with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-) and CD33 (-).
Seshi B; Kashyap A; Bennett JM
Br J Haematol; 1992 Jul; 81(3):374-7. PubMed ID: 1382546
[TBL] [Abstract][Full Text] [Related]
23. Acute myeloid leukemia M2 and t(8;21)(q22;q22) with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-), and CD33(-).
García Vela JA; Martin M; Delgado I; García Alonso L; Monteserin MC; Benito L; Somolinos N; Oña F
Ann Hematol; 1999 May; 78(5):237-40. PubMed ID: 10391105
[TBL] [Abstract][Full Text] [Related]
24. Immunotyping of blasts in refractory anaemia with excess of blasts.
Oertel J; Kleiner S; Huhn D
Br J Haematol; 1993 Jun; 84(2):305-9. PubMed ID: 7691147
[TBL] [Abstract][Full Text] [Related]
25. Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia.
Mehrotra B; George TI; Kavanau K; Avet-Loiseau H; Moore D; Willman CL; Slovak ML; Atwater S; Head DR; Pallavicini MG
Blood; 1995 Aug; 86(3):1139-47. PubMed ID: 7542497
[TBL] [Abstract][Full Text] [Related]
26. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
Kang LC; Dunphy CH
Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
[TBL] [Abstract][Full Text] [Related]
27. Analysis of CD34-positive cells in bone marrow from patients with myelodysplastic syndromes and acute myeloid leukemia and in normal individuals: a comparison between FACS analysis and immunohistochemistry.
Kanter-Lewensohn L; Hellström-Lindberg E; Kock Y; Elmhorn-Rosenborg A; Ost A
Eur J Haematol; 1996 Mar; 56(3):124-9. PubMed ID: 8598230
[TBL] [Abstract][Full Text] [Related]
28. Use of cell surface antigen phenotype in guiding therapeutic decisions in chronic myelomonocytic leukemia.
Woodlock TJ; Seshi B; Sham RL; Cyran EM; Bennett JM
Leuk Res; 1994 Mar; 18(3):173-81. PubMed ID: 7511190
[TBL] [Abstract][Full Text] [Related]
29. A novel translocation t(2;9)(q14;p12) in AML-M2 with an uncommon phenotype: myeloperoxidase-positive and myeloid antigen-negative.
Specchia G; Mestice A; Clelia Storlazzi T; Anelli L; Pannunzio A; Grazia Roberti M; Rocchi M; Liso V
Leuk Res; 2001 Jun; 25(6):501-7. PubMed ID: 11337024
[TBL] [Abstract][Full Text] [Related]
30. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
[TBL] [Abstract][Full Text] [Related]
31. Surface marker expression in acute myeloid leukaemia at first relapse.
Thomas X; Campos L; Archimbaud E; Shi ZH; Treille-Ritouet D; Anglaret B; Fiere D
Br J Haematol; 1992 May; 81(1):40-4. PubMed ID: 1381608
[TBL] [Abstract][Full Text] [Related]
32. Increased numbers of marrow basophils may be associated with a t(6;9) in ANLL.
Pearson MG; Vardiman JW; Le Beau MM; Rowley JD; Schwartz S; Kerman SL; Cohen MM; Fleischman EW; Prigogina EL
Am J Hematol; 1985 Apr; 18(4):393-403. PubMed ID: 3976650
[TBL] [Abstract][Full Text] [Related]
33. Detection of minimal residual disease in a patient having acute myelogenous leukemia with t(16;21)(p11;q22) treated by allogeneic bone marrow transplantation.
Okoshi Y; Shimizu S; Kojima H; Obara N; Mukai HY; Komeno T; Hasegawa Y; Mori N; Nagasawa T
Acta Haematol; 2001; 105(1):45-8. PubMed ID: 11340253
[TBL] [Abstract][Full Text] [Related]
34. [Clinical and cytogenetic studies of hematological malignancies with isolated trisomy 11].
Zhu Y; Xue Y; Pan J; Wu Y; Lu D
Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):425-7. PubMed ID: 12411047
[TBL] [Abstract][Full Text] [Related]
35. Morphologic, immunologic, and cytogenetic classification of acute myeloid leukemia and myelodysplastic syndrome in childhood: a report from the Childrens Cancer Group.
Barnard DR; Kalousek DK; Wiersma SR; Lange BJ; Benjamin DR; Arthur DC; Buckley JD; Kobrinsky N; Neudorf S; Sanders J; Miller LP; Shina DC; Hammond GD; Woods WG
Leukemia; 1996 Jan; 10(1):5-12. PubMed ID: 8558938
[TBL] [Abstract][Full Text] [Related]
36. Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117.
Haase D; Feuring-Buske M; Schäfer C; Schoch C; Troff C; Gahn B; Hiddemann W; Wörmann B
Leukemia; 1997 May; 11(5):674-9. PubMed ID: 9180291
[TBL] [Abstract][Full Text] [Related]
37. Triple immunofluorescence evaluation of CD15, CD34 and class II expression by flow cytometry in normal and leukemic bone marrows.
Venditti A; Del Poeta G; Stasi R; De Fabriitis P; Coppetelli U; Bruno A; Simone MD; Papa G
Haematologica; 1993; 78(6):359-63. PubMed ID: 7513673
[TBL] [Abstract][Full Text] [Related]
38. CD34+/CD33+ blast cells: correlation with FAB subtypes.
Rigolin GM; Lanza F; Ferrari L; Castoldi G
Leuk Lymphoma; 1995; 18 Suppl 1():43-8. PubMed ID: 7496354
[TBL] [Abstract][Full Text] [Related]
39. Clinical and morphological features of cases of trisomy 13 in acute non-lymphocytic leukemia.
Soni M; Brody J; Allen SL; Schulman P; Kolitz J; Rai K; Broome JD; Koduru PR
Leukemia; 1996 Apr; 10(4):619-23. PubMed ID: 8618437
[TBL] [Abstract][Full Text] [Related]
40. Triple Philadelphia chromosomes with major-bcr rearrangement in hypotriploid erythroleukaemia.
Yamamoto K; Nakamura Y; Arai H; Saito K; Furusawa S
Eur J Haematol; 2000 Sep; 65(3):182-7. PubMed ID: 11007054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
